CRISPR/Cas9-Mediated miR-29b Editing as a Treatment of Different Types of Muscle Atrophy in Mice is a research paper published in Molecular Therapy (2020). On theSindex it has a DataRank of 0. It has been cited 53 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: UG3 TR002463
National Institutes of Health
Grant: HL122547
National Natural Science Foundation of China
Grant: 81722008
National Natural Science Foundation of China
Grant: 81800358
National Natural Science Foundation of China
Grant: 81911540486
National Natural Science Foundation of China
Grant: 81900359
Science and Technology Commission of Shanghai Municipality
Grant: 18410722200
Science and Technology Commission of Shanghai Municipality
Grant: 17010500100
Shanghai Municipal Education Commission
Grant: 2017-01-07-00-09-E00042
Shanghai Municipal Education Commission
Grant: 19SG34
National Key Research and Development Program of China
Grant: 2018YFE0113500
NHLBI NIH HHS
Grant: R01 HL122547
National Natural Science Foundation of China
National Institutes of Health
Science and Technology Commission of Shanghai Municipality
FWCI
2.46
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Delivery of engineered extracellular vesicles with miR-29b editing system for muscle atrophy therapy
Additional file 1 of Delivery of engineered extracellular vesicles with miR-29b editing system for muscle atrophy therapy